STOCK TITAN

LeMaitre to Present at Upcoming Investor Conferences

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its participation in two significant investor conferences.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its participation in two significant investor conferences. David Roberts, President, will present at the Piper Sandler 34th Annual Healthcare Conference on November 30, 2022, at 3:10 PM ET in New York City. Additionally, he will present at the Sidoti Small-Cap Virtual Conference on December 8, 2022, at 1:15 PM ET. LeMaitre specializes in devices for treating peripheral vascular disease, impacting over 200 million individuals globally.

Loading...
Loading translation...
Argus Session date unavailable
+1.52% session move Open Argus
Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was +1.52%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BURLINGTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.

David Roberts, President, will present at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at the Lotte New York Palace in New York City. The company’s presentation is scheduled at 3:10 PM ET.

He is also scheduled to present at the Sidoti Small-Cap Virtual Conference on Thursday, December 8, 2022, at 1:15 PM ET.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com 


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will LeMaitre Vascular present at the Piper Sandler Conference?

LeMaitre Vascular will present at the Piper Sandler 34th Annual Healthcare Conference on November 30, 2022, at 3:10 PM ET.

What is the date of LeMaitre's presentation at the Sidoti Small-Cap Virtual Conference?

LeMaitre will present at the Sidoti Small-Cap Virtual Conference on December 8, 2022, at 1:15 PM ET.

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular's stock symbol is LMAT.

What medical condition does LeMaitre Vascular's products address?

LeMaitre Vascular provides products for the treatment of peripheral vascular disease.

How many people are affected by peripheral vascular disease worldwide?

Peripheral vascular disease affects more than 200 million people worldwide.

Keep reading